National Cancer Institute; Notice of Closed Meetings, 42023-42024 [2014-16854]
Download as PDF
<![CDATA[
42023
Federal Register / Vol. 79, No. 138 / Friday, July 18, 2014 / Notices
IV. Electronic Access
Persons with access to the Internet
may obtain the draft guidance at either
https://www.fda.gov/BiologicsBlood
Vaccines/GuidanceCompliance
RegulatoryInformation/Guidances/
default.htm or https://www.
regulations.gov.
Dated: July 14, 2014.
Peter Lurie,
Associate Commissioner for Policy and
Planning.
[FR Doc. 2014–16931 Filed 7–17–14; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request; A Generic Submission for
Formative Research, Pre-Testing,
Stakeholder Measures and Advocate
Forms at NCI
Summary: In compliance with the
requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
National Cancer Institute (NCI),
National Institutes of Health (NIH), will
publish periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
Written comments and/or suggestions
from the public and affected agencies
are invited on one or more of the
following points: (1) Whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
and materials while they are under
development. Additionally,
administrative forms are a necessary
part of collecting demographic
information and areas of interest for
advocates. Pre-testing, or formative
evaluation, helps ensure that the
products and services developed by NCI
have the greatest capacity of being
received, understood, and accepted by
their target audiences. Since OAR is
responsible for matching advocates to
NCI programs and initiatives across the
cancer continuum, it is necessary to
measure the satisfaction of both internal
and external stakeholders with this
collaboration. This customer satisfaction
research helps ensure the relevance,
utility, and appropriateness of the many
initiatives and products that OAR and
NCI produce. The OAR will use a
variety of qualitative (focus groups,
interviews) and quantitative (paper,
phone, in-person, and web surveys)
methodologies to conduct this research,
allowing NCI to: (1) Understand
characteristics (attitudes, beliefs, and
behaviors) of the intended target
audience and use this information in the
development of effective strategies,
concepts, activities; (2) use a feedback
loop to help refine, revise, and enhance
OAR’s efforts—ensuring that they have
the greatest relevance, utility,
appropriateness, and impact for/to
target audiences; and (3) expend limited
program resource dollars wisely and
effectively. The anticipated individual
respondents will consist of: Adult
cancer research advocates, members of
the public, health care professionals,
and organizational representatives.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
1,025.
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
To Submit Comments and for Further
Information: To obtain a copy of the
data collection plans and instruments,
submit comments in writing, or request
more information on the proposed
project, contact: Kelley Landy, Acting
Director of the Office of Advocacy
Relations (OAR), NCI, NIH, 31 Center
Drive, Bldg. 31, Room 10A28, MSC
2580, Bethesda, MD 20892, call nontoll-free number 301–594–3194, or
email your request, including your
address, to kelley.landy@mail.nih.gov.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
Proposed Collection: A Generic
Submission for Formative Research, Pretesting, Stakeholder Measures and
Advocate Forms at NCI, 0925–0641,
Revision, National Cancer Institute
(NCI), National Institutes of Health
(NIH).
Need and Use of Information
Collection: The Office of Advocacy
Relations (OAR) disseminates cancerrelated information to a variety of
stakeholders, seeks input and feedback,
and facilitates collaboration to advance
NCI’s authorized programs. It is
beneficial for NCI, through the OAR, to
pretest strategies, concepts, activities
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Individuals .....................
sroberts on DSK5SPTVN1PROD with NOTICES
Respondent type
Self-Administered Questionnaires .......................
Individual In-Depth Interviews ..............................
Focus Group Interviews .......................................
Dated: July 14, 2014.
Karla Bailey,
NCI Project Clearance Liaison, National
Institutes of Health.
[FR Doc. 2014–16908 Filed 7–17–14; 8:45 am]
BILLING CODE 4140–01–P
800
75
100
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
VerDate Mar<15>2010
23:20 Jul 17, 2014
Jkt 232001
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
Frequency of
response
1
1
1
Average time
per response
(minutes/hour)
Annual burden
hours
1
1
90/60
800
75
150
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
E:\FR\FM\18JYN1.SGM
18JYN1
42024
Federal Register / Vol. 79, No. 138 / Friday, July 18, 2014 / Notices
sroberts on DSK5SPTVN1PROD with NOTICES
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel Small
Grants Program for Epidemiology.
Date: July 23, 2014.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
2E032, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Gerald G. Lovinger, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, 9609 Medical Center Drive,
Room 7W266, Bethesda, MD 20892–8329,
240–276–6385.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Cancer
Institute Special Emphasis Panel, NCI U01
Review.
Date: August 26, 2014.
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
3W032/034, Rockville, MD 20850.
Contact Person: Ben Prickril, Ph.D.,
Scientific Review Officer, Research Program
and Review Branch, DEA, Division of
Extramural Activities, National Cancer
Institute, 9609 Medical Center Drive, Room
7W634, Rockville, MD 20850, 240–276–5794,
prickril@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel NCI
Program Project Meeting II (P01).
Date: September 30–October 1, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Rockville Hotel, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Majed M. Hamawy, Ph.D.,
MBA, Scientific Review Officer, Research
Programs Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
7W120, Rockville, MD 20850, 240–276–6457,
mh101v@nih.gov.
Name of Committee: National Cancer
Institute Initial Review Group Subcommittee
J—Career Development.
Date: October 29, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W640, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Ilda F. S. Melo, Ph.D.,
Scientific Review Officer, Resources and
Training Review Branch, Division of
VerDate Mar<15>2010
23:20 Jul 17, 2014
Jkt 232001
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W122, Rockville, MD 20850, 240–
276–6468, ilda.melo@mail.nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/sep/sep.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: July 14, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–16854 Filed 7–17–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute On Alcohol Abuse
and Alcoholism; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.); notice is
hereby given of a meeting of the Board
of Scientific Counselors, NIAAA.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Institute on Alcohol Abuse and
Alcoholism, including consideration of
personnel qualifications and
performance, and the competence of
individual investigators, the disclosure
of which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Board of Scientific
Counselors, NIAAA.
Date: August 26–27, 2014.
Time: 7:45 a.m. to 5:15 p.m.
Agenda: To review and evaluate personal
qualifications and performance; and
competence of individual investigators.
Place: National Institute of Health, 5635
Fisher Lane, Terrace Conference Center,
Bethesda, MD 20892.
Contact Person: George Kunos, M.D., Ph.D.,
Director, Division of Intramural Clinical and
Biological Research, National Institute on
Alcohol Abuse and Alcoholism, National
Institutes of Health, 5625 Fishers Lane, Room
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
2S–24A, Bethesda, MD 20892, 301–443–
2069, gkunos@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards, National
Institutes of Health, HHS).
Dated: July 14, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–16890 Filed 7–17–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Heart, Lung, and Blood
Advisory Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Heart, Lung,
and Blood Advisory Council.
Date: September 9, 2014.
Open: 8:00 a.m. to 5:00 p.m.
Agenda: To discuss program policies and
issues.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Bethesda, MD
20892.
Date: September 10, 2014.
Open: 8:00 a.m. to 12:00 p.m.
Agenda: To discuss program policies and
issues.
Place: National Institutes of Health,
Building 35A, Porter Building, Room 640,
35A Convent Drive, Bethesda, MD 20892.
Contact Person: Stephen C. Mockrin, Ph.D.,
Director, Division of Extramural Research
Activities, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6701
Rockledge Drive, Room 7100, Bethesda, MD
20892, (301) 435–0260, mockrins@nhlbi.
nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
E:\FR\FM\18JYN1.SGM
18JYN1
]]>Agencies
[Federal Register Volume 79, Number 138 (Friday, July 18, 2014)]
[Notices]
[Pages 42023-42024]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-16854]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material,
[[Page 42024]]
and personal information concerning individuals associated with the
grant applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel Small Grants Program for Epidemiology.
Date: July 23, 2014.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 2E032, Rockville, MD 20850, (Telephone Conference
Call).
Contact Person: Gerald G. Lovinger, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, 9609 Medical
Center Drive, Room 7W266, Bethesda, MD 20892-8329, 240-276-6385.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Cancer Institute Special Emphasis
Panel, NCI U01 Review.
Date: August 26, 2014.
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 3W032/034, Rockville, MD 20850.
Contact Person: Ben Prickril, Ph.D., Scientific Review Officer,
Research Program and Review Branch, DEA, Division of Extramural
Activities, National Cancer Institute, 9609 Medical Center Drive,
Room 7W634, Rockville, MD 20850, 240-276-5794,
prickril@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel NCI Program Project Meeting II (P01).
Date: September 30-October 1, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Rockville Hotel, 1750 Rockville Pike, Rockville,
MD 20852.
Contact Person: Majed M. Hamawy, Ph.D., MBA, Scientific Review
Officer, Research Programs Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, 7W120, Rockville, MD 20850, 240-276-6457, mh101v@nih.gov.
Name of Committee: National Cancer Institute Initial Review
Group Subcommittee J--Career Development.
Date: October 29, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W640, Rockville, MD 20850, (Telephone Conference
Call).
Contact Person: Ilda F. S. Melo, Ph.D., Scientific Review
Officer, Resources and Training Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W122, Rockville, MD 20850, 240-276-6468,
ilda.melo@mail.nih.gov.
Information is also available on the Institute's/Center's home
page: https://deainfo.nci.nih.gov/advisory/sep/sep.htm, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: July 14, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-16854 Filed 7-17-14; 8:45 am]
BILLING CODE 4140-01-P
